• 1
    Ueda K & Hayaishi O (1985) ADP-ribosylation. Annu Rev Biochem 54, 73100.
  • 2
    Krueger KM & Barbieri JT (1995) The family of bacterial ADP-ribosylating exotoxins. Clin Microbiol Rev 8, 3447.
  • 3
    Pallen MJ, Lam AC, Loman NJ & McBride A (2001) An abundance of bacterial ADP-ribosyltransferases – implications for the origin of exotoxins and their human homologues. Trends Microbiol 9, 302307; discussion 308.
  • 4
    Di Girolamo M & Corda D (2003) Mono-ADP-ribosylation of heterotrimeric G proteins. In Handbook of Cell Signalling (BradshawR & Dennis E, eds), Vol. 2, pp. 613618. Academic Press, San Diego.
  • 5
    Glowacki G, Braren R, Firner K, Nissen M, Kuhl M, Reche P, Bazan F, Cetkovic-Cvrlje M, Leiter E, Haag F & Koch-Nolte F (2002) The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci 11, 16571670.
  • 6
    Corda D & Di Girolamo M (2003) Functional aspects of protein mono-ADP-ribosylation. EMBO J 22, 19531958.
  • 7
    Okazaki IJ & Moss J (1999) Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases. Annu Rev Nutr 19, 485509.
  • 7a 
    Bürkle A (2005) Poly(ADP-ribose). The most elaborate metabolite of NAD+. FEBS J 272, doi: 10.1111/j1742-4658.2005.04864.x
  • 8
    Moss J, Stanley SJ, Nightingale MS, Murtagh JJ Jr, Monaco L, Mishima K, Chen HC, Williamson KC & Tsai SC (1992) Molecular and immunological characterization of ADP-ribosylarginine hydrolases. J Biol Chem 267, 1048110488.
  • 9
    Zolkiewska A & Moss J (1995) Processing of ADP-ribosylated integrin alpha 7 in skeletal muscle myotubes. J Biol Chem 270, 92279233.
  • 10
    Haag F, Koch-Nolte F, Kuhl M, Lorenzen S & Thiele HG (1994) Premature stop codons inactivate the RT6 genes of the human and chimpanzee species. J Mol Biol 243, 537546.
  • 11
    Braren R, Glowacki G, Nissen M, Haag F & Koch-Nolte F (1998) Molecular characterization and expression of the gene for mouse NAD+: arginine ecto-mono(ADP-ribosyl) transferase, Art1. Biochem J 336, 561568.
  • 12
    Bortell R, Kanaitsuka T, Stevens LA, Moss J, Mordes JP, Rossini AA & Greiner DL (1999) The RT6 (Art2) family of ADP-ribosyltransferases in rat and mouse. Mol Cell Biochem 193, 6168.
  • 13
    Haag F, Andresen V, Karsten S, Koch-Nolte F & Thiele H (1995) Both allelic forms of the rat T cell differentiation marker RT6 display nicotinamide adenine dinucleotide (NAD)-glycohydrolase activity, yet only RT6.2 is capable of automodification upon incubation with NAD. Eur J Immunol 25, 23552361.
  • 14
    Okazaki IJ, Zolkiewska A, Nightingale MS & Moss J (1994) Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases. Biochemistry 33, 1282812836.
  • 15
    Domenighini M, Magagnoli C, Pizza M & Rappuoli R (1994) Common features of the NAD-binding and catalytic site of ADP- ribosylating toxins. Mol Microbiol 14, 4150.
  • 16
    Domenighini M & Rappuoli R (1996) Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages. Mol Microbiol 21, 667674.
  • 17
    Takada T, Iida K & Moss J (1995) Conservation of a common motif in enzymes catalyzing ADP-ribose transfer. Identification of domains in mammalian transferases. J Biol Chem 270, 541544.
  • 18
    Hara N, Tsuchiya M & Shimoyama M (1996) Glutamic acid 207 in rodent T-cell RT6 antigens is essential for arginine-specific ADP-ribosylation. J Biol Chem 271, 2955229555.
  • 19
    Han S & Tainer JA (2002) The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases. Int J Med Microbiol 291, 523529.
  • 20
    Koch-Nolte F, Haag F, Braren R, Kuhl M, Hoovers J, Balasubramanian S, Bazan F & Thiele HG (1997) Two novel human members of an emerging mammalian gene family related to mono-ADP-ribosylating bacterial toxins. Genomics 39, 370376.
  • 21
    Grahnert A, Friedrich M, Pfister M, Haag F, Koch-Nolte F & Hauschildt S (2002) Mono-ADP-ribosyltransferases in human monocytes: regulation by lipopolysaccharide. Biochem J 362, 717723.
  • 22
    Stevens LA, Bourgeois C, Bortell R & Moss J (2003) Regulatory role of arginine 204 in the catalytic activity of rat alloantigens ART2a and ART2b. J Biol Chem 278, 1959119596.
  • 23
    Bazan JF & Koch-Nolte F (1997) Sequence and structural links between distant ADP-ribosyltransferase families. Adv Exp Med Biol 419, 99107.
  • 24
    Glowacki G, Braren R, Cetkovic-Cvrlje M, Leiter EH, Haag F & Koch-Nolte F (2001) Structure, chromosomal localization, and expression of the gene for mouse ecto-mono (ADP-ribosyl) transferase ART5. Gene 275, 267277.
  • 25
    Mueller-Dieckmann C, Ritter H, Haag F, Koch-Nolte F & Schulz GE (2002) Structure of the ecto-ADP-ribosyl transferase ART2.2 from rat. J Mol Biol 322, 687696.
  • 26
    Bourgeois C, Okazaki I, Cavanaugh E, Nightingale M & Moss J (2003) Identification of regulatory domains in ADP-ribosyltransferase-1 that determine transferase and NAD glycohydrolase activities. J Biol Chem 278, 2635126355.
  • 27
    Peterson JE, Larew JS & Graves DJ (1990) Purification and partial characterization of arginine-specific ADP- ribosyltransferase from skeletal muscle microsomal membranes. J Biol Chem 265, 1706217069.
  • 28
    Zolkiewska A, Nightingale MS & Moss J (1992) Molecular characterization of NAD: arginine ADP-ribosyltransferase from rabbit skeletal muscle. Proc Natl Acad Sci USA 89, 1135211356.
  • 29
    Zolkiewska A & Moss J (1993) Integrin alpha 7 as substrate for a glycosylphosphatidylinositol- anchored ADP-ribosyltransferase on the surface of skeletal muscle cell. J Biol Chem 268, 2527325276.
  • 30
    Paone G, Wada A, Stevens LA, Matin A, Hirayama T, Levine RL & Moss J (2002) ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc Natl Acad Sci USA 99, 82318235.
  • 31
    Yang D, Biragyn A, Kwak LW & Oppenheim JJ (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23, 291296.
  • 32
    Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P & Ho DD (2002) Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298, 9951000.
  • 33
    Corda D & Di Girolamo M (2002) Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling. Sci STKE 2002, PE53.
  • 34
    Jones EM & Baird A (1997) Cell-surface ADP-ribosylation of fibroblast growth factor-2 by an arginine-specific ADP-ribosyltransferase. Biochem J 323, 173177.
  • 35
    Boulle N, Jones EM, Auguste P & Baird A (1995) Adenosine diphosphate ribosylation of fibroblast growth factor-2. Mol Endocrinol 9, 767775.
  • 36
    Saxty BA, Yadollahi-Farsani M, Upton PD, Johnstone SR & MacDermot J (2001) Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase. Br J Pharmacol 133, 12191226.
  • 37
    Wang J, Nemoto E & Dennert G (1996) Regulation of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves ADP-ribosylation of a p56lck-associated protein. J Immunol 156, 28192827.
  • 38
    Liu ZX, Yu Y & Dennert G (1999) A cell surface ADP-ribosyltransferase modulates T cell receptor association and signaling. J Biol Chem 274, 1739917401.
  • 39
    Burstein D, Mordes JP, Greiner DL, Stein D, Nakamura N, Handler ES & Rossini AA (1989) Prevention of diabetes in BB/Wor rat by single transfusion of spleen cells. Parameters that affect degree of protection. Diabetes 38, 2430.
  • 40
    Greiner DL, Mordes JP, Handler ES, Angelillo M, Nakamura N & Rossini AA (1987) Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats. J Exp Med 166, 461475.
  • 41
    Greiner DL, Handler ES, Nakano K, Mordes JP & Rossini AA (1986) Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol 136, 148151.
  • 42
    Whalen BJ, Greiner DL, Mordes JP & Rossini AA (1994) Adoptive transfer of autoimmune diabetes mellitus to athymic rats: synergy of CD4+ and CD8+ T cells and prevention by RT6+ T cells. J Autoimmun 7, 819831.
  • 43
    Seman M, Adriouch S, Scheuplein F, Krebs C, Freese D, Glowacki G, Deterre P, Haag F & Koch-Nolte F (2003) NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19, 571582.
  • 44
    Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G & Baricordi OR (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97, 587600.
  • 45
    Scheuplein F, Adriouch S, Glowacki G, Haag F, Seman M & Koch-Nolte F (2003) Triggering of T-cell apoptosis by toxin-related ecto-ADP-ribosyltransferase ART2. Ann NY Acad Sci 1010, 296299.
  • 46
    Berthelier V, Tixier JM, Muller-Steffner H, Schuber F & Deterre P (1998) Human CD38 is an authentic NAD(P)+ glycohydrolase. Biochem J 330, 13831390.
  • 47
    Okazaki IJ, Kim HJ, McElvaney NG, Lesma E & Moss J (1996) Molecular characterization of a glycosylphosphatidylinositol-linked ADP-ribosyltransferase from lymphocytes. Blood 88, 915921.
  • 48
    Bruzzone S, Franco L, Guida L, Zocchi E, Contini P, Bisso A, Usai C & De Flora A (2001) A self-restricted CD38-connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J Biol Chem 276, 4830048308.
  • 49
    Ludden PW (1994) Reversible ADP-ribosylation as a mechanism of enzyme regulation in procaryotes. Mol Cell Biochem 138, 123129.
  • 50
    Lowery RG & Ludden PW (1988) Purification and properties of dinitrogenase reductase ADP-ribosyltransferase from the photosynthetic bacterium Rhodospirillum rubrum. J Biol Chem 263, 1671416719.
  • 51
    Frye RA (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 260, 273279.
  • 52
    Frye RA (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273, 793798.
  • 53
    Quan S, Venter H & Dabbs ER (1997) Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic. Antimicrob Agents Chemother 41, 24562460.
  • 54
    Spinelli SL, Kierzek R, Turner DH & Phizicky EM (1999) Transient ADP-ribosylation of a 2′-phosphate implicated in its removal from ligated tRNA during splicing in yeast. J Biol Chem 274, 26372644.
  • 55
    Lencer WI, Hirst TR & Holmes RK (1999) Membrane traffic and the cellular uptake of cholera toxin. Biochim Biophys Acta 1450, 177190.
  • 56
    Laitusis AL, Brostrom MA & Brostrom CO (1999) The dynamic role of GRP78/BiP in the coordination of mRNA translation with protein processing. J Biol Chem 274, 486493.
  • 57
    Leno GH & Ledford BE (1989) ADP-ribosylation of the 78-kDa glucose-regulated protein during nutritional stress. Eur J Biochem 186, 205211.
  • 58
    Staddon JM, Bouzyk MM & Rozengurt E (1992) Interconversion of GRP78/BiP. A novel event in the action of Pasteurella multocida toxin, bombesin, and platelet-derived growth factor. J Biol Chem 267, 2523925245.
  • 59
    Lupi R, Corda D & Di Girolamo M (2000) Endogenous ADP-ribosylation of the G protein beta subunit prevents the inhibition of type 1 adenylyl cyclase. J Biol Chem 275, 94189424.
  • 60
    Lupi R, Dani N, Dietrich A, Marchegiani A, Turacchio S, Berrie CP, Moss J, Gierschik P, Corda D & Di Girolamo M (2002) Endogenous mono-ADP-ribosylation of the free Gbetagamma prevents stimulation of phosphoinositide 3 kinase-gamma and phospholipase C- beta2 and Is activated by G-protein-coupled receptors. Biochem J 367, 825832.
  • 61
    Herrero-Yraola A, Bakhit SM, Franke P, Weise C, Schweiger M, Jorcke D & Ziegler M (2001) Regulation of glutamate dehydrogenase by reversible ADP-ribosylation in mitochondria. EMBO J 20, 24042412.
  •  61a 
    Choi MM, Huh JW, Yang SJ, Cho EH, Choi SY & Cho SW (2005) Identification of ADP-ribosylation site in human glutamate dehydrogenase isozymes. FEBS Lett 579, 41254130.
  • 62
    Di Girolamo M, Silletta MG, De Matteis MA, Braca A, Colanzi A, Pawlak D, Rasenick MM, Luini A & Corda D (1995) Evidence that the 50-kDa substrate of brefeldin A-dependent ADP- ribosylation binds GTP and is modulated by the G-protein beta gamma subunit complex. Proc Natl Acad Sci USA 92, 70657069.
  • 63
    De Matteis MA, Di Girolamo M, Colanzi A, Pallas M, Di Tullio G, McDonald LJ, Moss J, Santini G, Bannykh S, Corda D & Luini A (1994) Stimulation of endogenous ADP-ribosylation by brefeldin A. Proc Natl Acad Sci USA 91, 11141118.
  • 64
    Zhou H, Huiatt TW, Robson RM, Sernett SW & Graves DJ (1996) Characterization of ADP-ribosylation sites on desmin and restoration of desmin intermediate filament assembly by de-ADP-ribosylation. Arch Biochem Biophys 334, 214222.
  • 65
    Huang HY, Zhou H, Huiatt TW & Graves DJ (1996) Target proteins for arginine-specific mono (ADP-ribosyl) transferase in membrane fractions from chick skeletal muscle cells. Exp Cell Res 226, 147153.
  • 66
    Huang HY, Graves DJ, Robson RM & Huiatt TW (1993) ADP-ribosylation of the intermediate filament protein desmin and inhibition of desmin assembly in vitro by muscle ADP-ribosyltransferase. Biochem Biophys Res Commun 197, 570577.
  • 67
    Ablamunits V, Bridgett M, Duffy T, Haag F, Nissen M, Koch-Nolte F & Leiter H (2001) Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopathically-activated T cells in NOD/Lt mice. Diabetologia 44, 848858.
  • 68
    Matthes M, Hollmann C, Bertuleit H, Kuhl M, Thiele HG, Haag F & Koch-Nolte F (1997) ‘Natural’ RT6-1 and RT6-2 ‘knock-out’ mice. Adv Exp Med Biol 419, 271274.
  • 69
    Kanaitsuka T, Bortell R, Stevens LA, Moss J, Sardinha D, Rajan TV, Zipris D, Mordes JP, Greiner DL & Rossini AA (1997) Expression in BALB/c and C57BL/6 mice of Rt6–1 and Rt6–2 ADP-ribosyltransferases that differ in enzymatic activity: C57BL/6 Rt6–1 is a natural transferase knockout. J Immunol 159, 27412749.
  • 70
    Ohlrogge W, Haag F, Lohler J, Seman M, Littman DR, Killeen N & Koch-Nolte F (2002) Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice. Mol Cell Biol 22, 75357542.
  • 71
    Yau L, Litchie B & Zahradka P (2004) MIBG, an inhibitor of arginine-dependent mono(ADP-ribosyl)ation, prevents differentiation of L6 skeletal myoblasts by inhibiting expression of myogenin and p21 (cip1). Exp Cell Res 301, 320330.
  • 72
    Yau L, Litchie B, Thomas S, Storie B, Yurkova N & Zahradka P (2003) Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression. Eur J Biochem 270, 101110.
  • 73
    Faivre S, Regnauld K, Bruyneel E, Nguyen QD, Mareel M, Emami S & Gespach C (2001) Suppression of cellular invasion by activated G-protein subunits Gαo, Gαi1, Gαi2, and Gαi3 and sequestration of Gβγ. Mol Pharmacol 60, 363372.
  • 74
    Bookout AL, Finney AE, Guo R, Peppel K, Koch WJ & Daaka Y (2003) Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth. J Biol Chem 278, 3756937573.